Vital KSK Holdings (FRA:4GX) EPS without NRI: €0.59 (TTM As of Mar. 2026)


FRA:4GX Vital KSK Holdings Inc FRA:4GX
70 GF Score
Price €8.30
GF Value €7.05
! 6 Warning Signs
View Full Analysis

What is Vital KSK Holdings EPS without NRI?

Vital KSK Holdings FRA:4GX 70 EPS without NRI is €0.59 as of Mar. 2026. GuruFocus rates FRA:4GX with a GF Score™ of 70/100 and a GF Value™ of €7.05. The stock has 6 warning signs investors should review. Among 101 Medical Distribution companies, Vital KSK Holdings ranks better than 72.28% on this metric.

Vital KSK Holdings's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €0.08. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €0.59.

During the past 12 months, Vital KSK Holdings's average earnings per share (NRI) Growth Rate was 10.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 15.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Vital KSK Holdings's EPS without NRI or its related term are showing as below:

FRA:4GX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -14   Med: 4.4   Max: 33.9
Current: 15.1

During the past 13 years, Vital KSK Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 33.90% per year. The lowest was -14.00% per year. And the median was 4.40% per year.

FRA:4GX's 3-Year EPS without NRI Growth Rate is ranked better than
72.28% of 101 companies
in the Medical Distribution industry
Industry Median: 2.6 vs FRA:4GX: 15.10

Vital KSK Holdings's EPS (Diluted) for the three months ended in Mar. 2026 was €0.17. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.87.

Vital KSK Holdings's EPS (Basic) for the three months ended in Mar. 2026 was €0.17. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.87.


Vital KSK Holdings  (FRA:4GX) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Vital KSK Holdings EPS without NRI Related Terms


Vital KSK Holdings EPS without NRI Historical Data

* Premium members only.

The historical data trend for Vital KSK Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vital KSK Holdings EPS without NRI Chart

Vital KSK Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.47 0.54 0.58 0.56

Vital KSK Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.34 0.11 0.08

FRA:4GX vs MCK, CAH, COR: EPS without NRI Comparison

For the Medical Distribution subindustry, Vital KSK Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vital KSK Holdings PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Vital KSK Holdings's PE Ratio without NRI falls into.


FRA:4GX
70GF Score
Vital KSK Holdings Inc FRA:4GX
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vital KSK Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €0.59 mean?
Vital KSK Holdings (FRA:4GX) has a EPS without NRI of €0.59 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Vital KSK Holdings and its competitors. According to the industry distribution chart, Vital KSK Holdings ranks #28 out of 101 companies in the Medical Distribution industry, placing it in the top 27.7%.
Is Vital KSK Holdings' EPS without NRI too high?
Vital KSK Holdings' current EPS without NRI is €0.59. Based on the distribution chart, Vital KSK Holdings ranks #28 out of 101 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' EPS without NRI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #28 out of 101 companies for EPS without NRI. This puts Vital KSK Holdings in the upper half of its industry. The industry median EPS without NRI is 2.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.60, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current EPS without NRI is €0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Vital KSK Holdings (FRA:4GX) has a current EPS without NRI of €0.59. The stock's GF Value™ is €7.05, compared to a current price of €8.30 — trading 17.7% above its estimated fair value. The current EPS without NRI is €0.59. Vital KSK Holdings' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Vital KSK Holdings (FRA:4GX), the current EPS without NRI is €0.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vital KSK Holdings (FRA:4GX) Overvalued in 2026?

Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued. The current stock price of €8.30 is trading 17.7% above its estimated GF Value™ of €7.05.

Key valuation signals for FRA:4GX:

  • EPS without NRI: €0.59
  • GF Value™: €7.05 vs. price of €8.30 (17.7% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the FRA:4GX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vital KSK Holdings Business Description

Other Exchanges 3151:Japan
Address 1-1-12 Tsurumaki, Setagaya-ku, JPN, 154-0016
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
70GF Score

Get the complete analysis for FRA:4GX

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.30
Price
€7.05
GF Value